144.00
+2.70
+(1.91%)
As of 9:50:16 AM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
673,026
695,097
753,852
622,674
782,404
Cost of Revenue
361,691
410,540
433,814
367,247
395,264
Gross Profit
311,335
284,557
320,038
255,427
387,140
Operating Expense
196,424
175,763
174,125
156,407
145,611
Operating Income
114,911
108,794
145,913
99,020
241,529
Net Non Operating Interest Income Expense
50,507
50,508
36,934
30,358
29,111
Pretax Income
183,210
166,286
190,842
126,364
267,349
Tax Provision
47,564
43,860
49,127
33,050
67,513
Net Income Common Stockholders
135,654
122,430
141,715
93,314
199,837
Diluted NI Available to Com Stockholders
135,654
122,430
141,715
93,314
199,837
Basic EPS
13.24
11.95
13.83
9.11
19.51
Diluted EPS
13.24
11.95
13.83
9.11
19.51
Basic Average Shares
10,245.67
10,245
10,245
10,245
10,245
Diluted Average Shares
10,250
10,245
10,245
10,245
10,245
Rent Expense Supplemental
--
3,682
3,682
3,682
3,682
Total Expenses
558,115
586,303
607,939
523,654
540,875
Net Income from Continuing & Discontinued Operation
135,654
122,430
141,715
93,314
199,837
Normalized Income
135,652.52
122,428.53
142,602.38
98,072.60
207,231.74
Interest Income
--
50,523
36,945
30,367
29,185
Interest Expense
1
--
--
--
69
Net Interest Income
50,507
50,508
36,934
30,358
29,111
EBIT
183,211
166,286
190,842
99,020
267,418
EBITDA
203,421
185,696
208,576
116,911
284,640
Reconciled Cost of Revenue
361,691
410,540
433,814
367,247
395,264
Reconciled Depreciation
20,210
19,410
17,734
17,891
17,222
Net Income from Continuing Operation Net Minority Interest
135,654
122,430
141,715
93,314
199,837
Total Unusual Items Excluding Goodwill
2
2
-1,195
-6,444
-9,893
Total Unusual Items
2
2
-1,195
-6,444
-9,893
Normalized EBITDA
203,419
185,694
209,771
123,355
294,533
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0.52
0.53
-307.62
-1,685.40
-2,498.26
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SUNLOC.BO Sunil Healthcare Limited
79.60
+9.19%
ANUHPHR.BO Anuh Pharma Limited
174.10
+1.31%
PANCHSHEEL.BO Panchsheel Organics Limited
151.00
+2.76%
HIKAL.BO Hikal Limited
418.70
-0.08%
NATCAPSUQ.BO Natural Capsules Limited
213.00
+0.47%
PARMAX.BO Parmax Pharma Limited
44.50
-9.07%
CORALAB.BO Coral Laboratories Limited
644.50
+2.27%
BAJAJHCARE.BO Bajaj HealthCare Limited
606.35
+4.70%
AARTIPHARM.BO Aarti Pharmalabs Limited
693.40
+2.14%
LUPIN.BO Lupin Limited
2,019.90
+2.58%